Table 1.
Hospitalized patients N = 198 | Hospital outpatients N = 129 | Primary care outpatients N = 63 | p value global | p value-adjusted hospitalized patients vs hospital outpatients | p value-adjusted hospitalized patients vs primary care outpatients | p value-adjusted hospital outpatient vs primary care outpatients | |
---|---|---|---|---|---|---|---|
Age (years) | 66 (55–77.6) | 43 (32–54) | 42.5 (33–50.8) | < 0.001 | < 0.001 | < 0.001 | 0.832 |
Female | 72 (36%) | 73 (57%) | 43 (68%) | < 0.001 | 0.157 | < 0.001 | < 0.001 |
HTA | 80 (40%) | 15 (12%) | 16 (25%) | < 0.001 | < 0.001 | 0.049 | 0.030 |
Diabetes | 52 (26%) | 6 (5%) | 3 (5%) | < 0.001 | < 0.001 | < 0.001 | 1.00 |
Obesity | 22 (11%) | 9 (7%) | 6 (10%) | 0.476 | |||
Bronchopathy | 33 (17%) | 14 (11%) | 5 (8%) | 0.127 | |||
Cardiopathy | 39 (20%) | 2 (2%) | 4 (6%) | < 0.001 | < 0.001 | 0.017 | 0.092 |
Nephropathy | 19 (10%) | 1 (1%) | 0 (0%) | < 0.001 | 0.002 | 0.014 | 1.00 |
Neurological diseases | 26 (13%) | 1 (1%) | 1 (2%) | < 0.001 | < 0.0001 | 0.011 | 0.55 |
Cancer | 23 (12%) | 2 (2%) | 1 (2%) | < 0.001 | 0.001 | 0.019 | 1.00 |
Hemopathy | 13 (7%) | 1 (1%) | 2 (3%) | 0.0022 | 0.032 | 0.534 | 0.377 |
Graft | 7 (4%) | 2 (2%) | 0 (0%) | 0.269 | |||
Other immunosuppression* | 17 (9%) | 4 (3%) | 3 (5%) | 0.106 |
*HIV, autoimmune disease, inflammatory disease, sickle cell anemia. Data expressed in median (IQR) for continuous variables or N (%) for qualitative data